BMRN
NASDAQ
US
BioMarin Pharmaceutical Inc. - Common Stock
$55,50
▼ $-1,74
(-3,04%)
Vol. 2.3M
12
Punteggio di Qualità
ok
Analisi approfondita
2/5
ok
Ricavi ✓
Utile netto ✓
>IPO ✗
Cap. mercato
$11.4B
P/E
21,9
ROE
8,8%
Margine
16,8%
D/E
9,85
Beta
0,26
52W
$51–$74
Consenso Wall Street
31 analisti · Apr 202610
Acquisto forte
15
Compra
6
Mantieni
0
Vendi
0
Vendita forte
80,6%
Rating Compra
Grafico dei Prezzi
Titoli simili
Utili
Tasso di battuta: 50,0%| Trimestre | EPS Stimato | EPS Effettivo | Sorpresa |
|---|---|---|---|
| Dic 2025 | $0,64 | $-0,24 | $-0,88 |
| Set 2025 | $0,38 | $-0,16 | $-0,54 |
| Giu 2025 | $0,85 | $1,23 | +$0,38 |
| Mar 2025 | $0,72 | $0,95 | +$0,23 |
Ricavi e utili trimestrali
| Trimestre | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|
| Ricavi | $747.3M | $745.1M | $825.4M | $776.1M | $874.6M |
| Utile netto | $124.9M | $185.7M | $240.5M | -$30.7M | -$46.6M |
Trend fondamentali
| Metrica | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | 11.5% | 11.5% | 11.5% | 11.5% | 8.8% | 8.8% |
| P/E (TTM) | 16.04 | 17.06 | 16.21 | 15.66 | 20.09 | 21.94 |
| Net Margin | 29.1% | 21.4% | 21.4% | 21.4% | 16.8% | 16.8% |
| Gross Margin | 81.8% | 79.6% | 79.6% | 79.6% | 81.3% | 81.3% |
| D/E Ratio | 9.89 | 9.89 | 9.89 | 9.89 | 9.85 | 9.85 |
| Current Ratio | 5.56 | 5.56 | 5.56 | 5.56 | 4.83 | 4.83 |
Rapporti chiave
ROA (TTM)
7,1%
P/S (TTM)
3,69
P/B
2,2
EPS (TTM)
$2,64
CF/Share
$1,30
Crescita ricavi 3A
+15,6%
52W High
$73,51
52W Low
$50,76
$50,76
Intervallo 52 settimane
$73,51
Salute finanziaria
Flusso di cassa libero
$56.6M
Debito netto
-$705.8M
Liquidità
$1.3B
Debito totale
$605.9M
Aggiornato al Dic 31, 2025
Як BMRN виглядає на тлі конкурентів у Biotechnology?
Група порівняння: Micro-cap Biotechnology (All) · 528 компаній
Оцінка BMRN vs аналоги Biotechnology
P/E
21,9
▲
17%
sopra
peer
(18,8)
vs Peer
vs Settore
Sottovalutato
P/S
3,7
▼
71%
sotto
peer
(12,9)
vs Peer
vs Settore
Sottovalutato
P/B
2,2
▼
10%
sotto
peer
(2,5)
vs Peer
vs Settore
Valore equo
Дивідендна дохідність
—
▼
0%
sotto
peer
(0,0%)
vs Peer
vs Settore
Rendimento basso
Прибутковість BMRN vs аналоги Biotechnology
ROE
8,8%
▲
113%
sopra
peer
(-67,3%)
vs Peer
vs Settore
Top livello
Net margin
16,8%
▲
106%
sopra
peer
(-286,8%)
vs Peer
vs Settore
Sotto media
Валова маржа
81,3%
▲
3%
sopra
peer
(78,6%)
vs Peer
vs Settore
Debole
ROA
7,1%
▲
115%
sopra
peer
(-46,7%)
vs Peer
vs Settore
Top livello
Фінансове здоровʼя BMRN vs аналоги Biotechnology
D/E ratio
9,9
▼
0%
sotto
peer
(0,0)
vs Peer
vs Settore
Debito alto
Поточна ліквідність
4,8
▲
9%
sopra
peer
(4,4)
vs Peer
vs Settore
In linea
Beta
0,3
▼
73%
sotto
peer
(1,0)
vs Peer
vs Settore
Più volatile
Радар фундаменталів BMRN
BMRN
Mediana peer
Industria
BMRN прибутковість vs борг
Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio
BMRN vs аналоги: ключові метрики
Attività insider
NeutralAcquisti
0
Vendite
0
DAVIS GEORGE ERIC
Officer · Mar 16
14570 shs
GUYER CHARLES GREG
Chief Technology Officer · Mar 16
14990 shs
HARDY ALEXANDER
Chief Executive Officer · Mar 16
62440 shs
HUBBARD CRISTIN
Officer · Mar 16
15410 shs
FRIBERG GREGORY R
Officer · Mar 16
19150 shs
MUELLER BRIAN R
Chief Financial Officer · Mar 16
18740 shs
GUYER CHARLES GREG
Chief Technology Officer · Mar 11
16486 shs
FRIBERG GREGORY R
Officer · Feb 26
6326 shs
DAVIS GEORGE ERIC
Officer · Feb 26
26061 shs
DAVIS GEORGE ERIC
Officer · Feb 25
15224 shs
Ultimo 90 giorni
Principali azionisti
Top 5: 38,45%Blackrock Inc.
9,95%
$1.0B
Vanguard Group Inc
9,43%
$981.4M
Dodge & Cox Inc.
7,58%
$788.9M
Primecap Management Company
7,57%
$787.7M
NORGES BANK
3,92%
$407.7M
Aggiornato al Dic 31, 2025